{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:08:36Z","timestamp":1792541316376,"version":"4.5.0"},"reference-count":104,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Ophthalmol"],"published-print":{"date-parts":[[2020]]},"DOI":"10.4103\/ijo.ijo_816_20","type":"journal-article","created":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T13:06:33Z","timestamp":1597928793000},"page":"1799","source":"Crossref","is-referenced-by-count":67,"title":["Drug-induced uveitis: A review"],"prefix":"10.4103","volume":"68","author":[{"given":"Manisha","family":"Agarwal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parthopratim","family":"Dutta Majumder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalpana","family":"Babu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"VinayaKumar","family":"Konana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mallika","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Touhami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinu","family":"Stanescu-Segall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahram","family":"Bodaghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0301-4738.292592-1","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2165\/00002018-199717030-00005","article-title":"Drug-induced uveitis.Incidence, prevention and treatment","author":"Fraunfelder","year":"1997","journal-title":"Drug Saf"},{"key":"key-10.4103\/0301-4738.292592-2","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1869-5760-3-43","article-title":"Drug-induced uveitis","author":"London","year":"2013","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"key-10.4103\/0301-4738.292592-3","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1097\/ICU.0000000000000530","article-title":"Drug-induced uveitis","author":"Moorthy","year":"2018","journal-title":"Curr Opin Ophthalmol"},{"key":"key-10.4103\/0301-4738.292592-4","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1517\/14740338.2015.972363","article-title":"Drug-induced uveitis","author":"Cordero-Coma","year":"2015","journal-title":"Expert Opin Drug Saf"},{"key":"key-10.4103\/0301-4738.292592-5","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0039-6257(97)00130-6","article-title":"Drug-induced uveitis","author":"Moorthy","year":"1998","journal-title":"Surv Ophthalmol"},{"key":"key-10.4103\/0301-4738.292592-6","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1089\/jop.1986.2.385","article-title":"31.Oculotoxicities of systemically administered drugs","author":"Koneru","year":"1986","journal-title":"J Ocul Pharmacol"},{"key":"key-10.4103\/0301-4738.292592-7","first-page":"1429","article-title":"Systemic vasculitis following influenza vaccination-report of 3 cases and literature review","author":"Mader","year":"1993","journal-title":"J Rheumatol"},{"key":"key-10.4103\/0301-4738.292592-8","first-page":"60","article-title":"Hong Kong treatment services-royal postgraduate medical school-british medical research council co-operative study of rifampicin plus ethambutol in daily and intermittent regimens.The detection of rifampicin-dependent antibodies","author":"Worlledge","year":"1973","journal-title":"Scand J Respir Dis"},{"key":"key-10.4103\/0301-4738.292592-9","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/S0002-9394(14)72550-4","article-title":"Acute uveitis associated with rifabutin use in patients with human immunodeficiency virus infection","author":"Jacobs","year":"1994","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0301-4738.292592-10","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1056\/NEJM199402103300616","article-title":"Uveitis and pseudojaundice during a regimen of clarithromycin, rifabutin, and ethambutol.MAC Study Group of the Canadian HIV Trials Network","author":"Shafran","year":"1994","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0301-4738.292592-11","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/00002030-199005000-00009","article-title":"Dose-limiting toxicity of rifabutin in AIDS-related complex: Syndrome of arthralgia\/arthritis","author":"Siegal","year":"1990","journal-title":"AIDS"},{"key":"key-10.4103\/0301-4738.292592-12","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/327324a0","article-title":"Evidence for neuromelanin involvement in MPTP- induced neurotoxicity","author":"D'Amato","year":"1987","journal-title":"Nature"},{"key":"key-10.4103\/0301-4738.292592-13","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.3109\/03602538409033561","article-title":"The melanin binding of drugs and its implications","author":"Ings","year":"1984","journal-title":"Drug Metab Rev"},{"key":"key-10.4103\/0301-4738.292592-14","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1089\/jop.1994.10.217","article-title":"Relevance of drug-melanin interactions to ocular pharmacology and toxicology","author":"Salazar-Bookaman","year":"1994","journal-title":"J Ocul Pharmacol"},{"key":"key-10.4103\/0301-4738.292592-15","doi-asserted-by":"crossref","unstructured":"Broekhuyse RM, Kuhlmann ED, Winkens HJ. Experimental autoimmune anterior uveitis (EAAU). III. Induction by immunization with purified uveal and skin melanins. Exp Eye Res 1993;56:575-83.","DOI":"10.1006\/exer.1993.1071"},{"key":"key-10.4103\/0301-4738.292592-16","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/0002-9394(74)90448-6","article-title":"Corticosteroid-induced uveitis","author":"Martins","year":"1974","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0301-4738.292592-17","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.intimp.2018.06.001","article-title":"Immune checkpoint blockade therapy for cancer: An overview of FDA approved immune checkpoint inhibitors","author":"Hargardon","year":"2018","journal-title":"Int Immunopharmacol"},{"key":"key-10.4103\/0301-4738.292592-18","first-page":"1397","article-title":"Tuberculous uveitis after treatment with etanercept","author":"Fonollosa","year":"39;s","journal-title":"Graefe"},{"key":"key-10.4103\/0301-4738.292592-19","first-page":"35","article-title":"Why does tumor necrosis factor targeted therapy reactivate tuberculosis?","author":"Ehlers","year":"2005","journal-title":"J Rheumatol Suppl"},{"key":"key-10.4103\/0301-4738.292592-20","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"key-10.4103\/0301-4738.292592-21","unstructured":"Holloway K, Green T. Drug and Therapeutics Committees: A Practical Guide. WHO Department of Essential Drugs and Medicines Policy, Geneva, Switzerland; 2003. Available from: http:\/\/apps.who.int\/medicinedocs\/pdf\/s4882e\/s4882e.pdf. [Last accessed on Feb 2020]."},{"key":"key-10.4103\/0301-4738.292592-22","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1001\/archopht.1997.01100150735008","article-title":"Iritis and hypotony after treatment with intravenous cidofovir for cytomegalovirus retinitis","author":"Davis","year":"1997","journal-title":"Arch Ophthalmol"},{"key":"key-10.4103\/0301-4738.292592-23","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1001\/archopht.1994.01090210043015","article-title":"Hypopyon uveitis in patients with acquired immunodeficiency syndrome treated for systemic Mycobacterium avium complex infection with rifabutin","author":"Saran","year":"1994","journal-title":"Arch Ophthalmol"},{"key":"key-10.4103\/0301-4738.292592-24","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1086\/517366","article-title":"Determinants of rifabutin-associated uveitis in patients treated with rifabutin, clarithromycin, and ethambutol for Mycobacterium avium complex bacteremia: A multivariate analysis.Canadian HIV Trials Network Protocol 010 Study Group","author":"Shafran","year":"1998","journal-title":"J Infect Dis"},{"key":"key-10.4103\/0301-4738.292592-25","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/8756-3282(95)00448-3","article-title":"Interleukin-6 and tumor necrosis factor alpha levels after bisphosphonates treatment in vitro and in patients with malignancy","author":"Sauty","year":"1996","journal-title":"Bone"},{"key":"key-10.4103\/0301-4738.292592-26","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1056\/NEJM200303203481225","article-title":"Bisphosphonates and ocular inflammation","author":"Fraunfelder","year":"2003","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0301-4738.292592-27","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.1600-0420.1997.tb00783.x","article-title":"Bilateral anterior uveitis and retinal haemorrhages after administration of trimethoprim","author":"Kristinsson","year":"1997","journal-title":"Acta Ophthalmol Scand"},{"key":"key-10.4103\/0301-4738.292592-28","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/S0140-6736(05)79382-X","article-title":"Arthritis, uveitis, and Stevens-Johnson syndrome induced by trimethoprim","author":"Arola","year":"1998","journal-title":"Lancet"},{"key":"key-10.4103\/0301-4738.292592-29","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s13023-017-0677-2","article-title":"Tubulointerstitial nephritis and uveitis (TINU) syndrome: A systematic review of its epidemiology, demography and risk factors","author":"Okafor","year":"2017","journal-title":"Orphanet J Rare Dis"},{"key":"key-10.4103\/0301-4738.292592-30","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0039-6257(01)00261-2","article-title":"The tubulointerstitial nephritis and uveitis syndrome","author":"Mandeville","year":"2001","journal-title":"Surv Ophthalmol"},{"key":"key-10.4103\/0301-4738.292592-31","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.ophtha.2007.01.002","article-title":"Enhanced recognition, treatment, and prognosis of tubulointerstitial nephritis and uveitis syndrome","author":"Mackensen","year":"2007","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.292592-32","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/tan.12116","article-title":"HLA associations with tubulointerstitial nephritis with or without uveitis in Finnish peadiatric population: A nation-wide study","author":"Per\u00e4saari","year":"2013","journal-title":"Tissue Antigens"},{"key":"key-10.4103\/0301-4738.292592-33","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2215\/CJN.02540313","article-title":"Tubulointerstitial nephritis with uveitis in Chinese adults","author":"Li","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"key-10.4103\/0301-4738.292592-34","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3899\/jrheum.110865","article-title":"Scleritis: A paradoxical effect of etanercept.Etanercept-associated inflammatory eye disease?","author":"Gaujoux-Viala","year":"2012","journal-title":"J Rheumatol"},{"key":"key-10.4103\/0301-4738.292592-35","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.autrev.2009.10.003","article-title":"BIOGEAS Study Group.Autoimmune diseases induced by biological agents: A double-edged sword?","author":"Ramos-Casals","year":"2010","journal-title":"Autoimmun Rev"},{"key":"key-10.4103\/0301-4738.292592-36","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.berh.2008.09.008","article-title":"Autoimmune diseases induced by TNF-targeted therapies","author":"Ramos-Casals","year":"2008","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"key-10.4103\/0301-4738.292592-37","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3109\/09273948.2011.623213","article-title":"Sarcoid-related uveitis occurring during adalimumab therapy","author":"Seve","year":"2012","journal-title":"Ocul Immunol Inflamm"},{"key":"key-10.4103\/0301-4738.292592-38","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1001\/archopht.1986.01050180097039","article-title":"Treatment of onchocerciasis.The ocular effects of ivermectin and diethylcarbamazine","author":"Taylor","year":"1986","journal-title":"Arch Ophthalmol"},{"key":"key-10.4103\/0301-4738.292592-39","doi-asserted-by":"crossref","first-page":"529","DOI":"10.4269\/ajtmh.1985.34.529","article-title":"The Mazzotti reaction following treatment of onchocerciasis with diethylcarbamazine: Clinical severity as a function of infection intensity","author":"Francis","year":"1985","journal-title":"Am J Trop Med Hyg"},{"key":"key-10.4103\/0301-4738.292592-40","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1136\/bjo.64.3.191","article-title":"Changes in visual function and in the posterior segment of the eye during treatment of onchocerciasis with diethylcarbamazine citrate","author":"Bird","year":"1980","journal-title":"Br J Ophthalmol"},{"key":"key-10.4103\/0301-4738.292592-41","first-page":"1210","article-title":"Uveal effusion and secondary angle-closure glaucoma associated with topiramate use","author":"Sankar","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"key-10.4103\/0301-4738.292592-42","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.mjafi.2012.07.019","article-title":"Topiramate induced bilateral anterior uveitis with choroidal detachment and angle closure glaucoma","author":"Dhar","year":"2015","journal-title":"Med J Armed Forces India"},{"key":"key-10.4103\/0301-4738.292592-43","doi-asserted-by":"crossref","unstructured":"Eadie B, Etminan M, Mikelberg FS. Risk of uveitis with oral moxifloxacin: A comparative safety study. JAMA Ophthalmol 2015;133:81-4.","DOI":"10.1001\/jamaophthalmol.2014.3598"},{"key":"key-10.4103\/0301-4738.292592-44","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1038\/eye.2010.19","article-title":"Uveitis-like syndrome and iris transillumination after the use of oral moxifloxacin","author":"Willermain","year":"2010","journal-title":"Eye (Lond)"},{"key":"key-10.4103\/0301-4738.292592-45","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1001\/jamaophthalmol.2015.4092","article-title":"Oral fluoroquinolones and the risk of uveitis","author":"Sandhu","year":"2016","journal-title":"JAMA Ophthalmol"},{"key":"key-10.4103\/0301-4738.292592-46","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00417-017-3835-2","article-title":"Checkpoint inhibitor-induced uveitis: A case series","author":"Conrady","year":"2018","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"key-10.4103\/0301-4738.292592-47","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1097\/IAE.0000000000002181","article-title":"Checkpoint inhibitor immune && therapy: Systemic indications and ophthalmic side effects","author":"Dalvin","year":"2018","journal-title":"Retina"},{"key":"key-10.4103\/0301-4738.292592-48","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1111\/1346-8138.13612","article-title":"Case of acute anterior uveitis and Vogt- Koyanagi-Harada syndrome-like eruptions induced by nivolumab in a melanoma patient","author":"Arai","year":"2017","journal-title":"J Dermatol"},{"key":"key-10.4103\/0301-4738.292592-49","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/ccr3.911","article-title":"Vogt-Koyanagi-Harada disease-like posterior uveitis in the course of nivolumab (anti-PD-1 antibody), interposed by vemurafenib (BRAF inhibitor), for metastatic cutaneous malignant melanoma","author":"Matsuo","year":"2017","journal-title":"Clin Case Rep"},{"key":"key-10.4103\/0301-4738.292592-50","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/1346-8138.14273","article-title":"HLA-DRB1*04:05 in two cases of Vogt-Koyanagi-Harada disease-like uveitis developing from an advanced melanoma patient treated by sequential administration of nivolumab and dabrafenib\/trametinib therapy","author":"Fujimura","year":"2018","journal-title":"J Dermatol"},{"key":"key-10.4103\/0301-4738.292592-51","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/CJI.0000000000000154","article-title":"Vogt-Koyanagi-Harada-like syndrome complicating pembrolizumab treatment for metastatic melanoma","author":"Bricout","year":"2017","journal-title":"J Immunother"},{"key":"key-10.4103\/0301-4738.292592-52","doi-asserted-by":"crossref","first-page":"944","DOI":"10.3389\/fonc.2019.00944","article-title":"Pembrolizumab induced ocular hypotony with near complete vision loss, interstitial pulmonary fibrosis and arthritis","author":"Nguyen","year":"2019","journal-title":"Front Oncol"},{"key":"key-10.4103\/0301-4738.292592-53","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.ajo.2014.07.003","article-title":"Ocular toxicity in BRAF mutant cutaneous melanoma patients treated with vemurafenib","author":"Choe","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0301-4738.292592-54","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1001\/jamaophthalmol.2014.3024","article-title":"Uveitis in patients with late- stage cutaneous melanoma treated with vemurafenib","author":"Guedj","year":"2014","journal-title":"JAMA Ophthalmol"},{"key":"key-10.4103\/0301-4738.292592-55","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1159\/000357060","article-title":"Uveitis as a result of MAP kinase pathway inhibition","author":"Joshi","year":"2013","journal-title":"Case Rep Ophthalmol"},{"key":"key-10.4103\/0301-4738.292592-56","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1080\/09273940590928562","article-title":"Steroid hypopyon following intravitreal triamcinolone acetonide injection in a pseudophakic patient","author":"Amato","year":"2005","journal-title":"Ocul Immunol Inflamm"},{"key":"key-10.4103\/0301-4738.292592-57","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa054481","article-title":"Ranibizumab for neovascular age-related macular degeneration","author":"Rosenfeld","year":"2006","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0301-4738.292592-58","doi-asserted-by":"crossref","unstructured":"Brown DM, Michels M, Kaiser PK, Heier JS, Sy JP, Ianchulev T, et al. Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: Two-year results of the ANCHOR study. Ophthalmology 2009;116:57-65.e5.","DOI":"10.1016\/j.ophtha.2008.10.018"},{"key":"key-10.4103\/0301-4738.292592-59","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1023\/B:PHAM.0000029275.41323.a6","article-title":"Structure-immunogenicity relationships of therapeutic proteins","author":"Hermeling","year":"2004","journal-title":"Pharm Res"},{"key":"key-10.4103\/0301-4738.292592-60","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/ICB.0b013e3182964f7c","article-title":"Sequential, acute non- infectious uveitis associated with separate intravitreal injections of bevacizumab and ranibizumab","author":"Cunningham","year":"2013","journal-title":"Retina Cases Brief Rep"},{"key":"key-10.4103\/0301-4738.292592-61","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ophtha.2019.04.017","article-title":"HAWK and HARRIER: Phase 3, multicenter, randomized, double-masked trials of brolucizumab for neovascular age-related macular degeneration","author":"Dugel","year":"2020","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.292592-62","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1136\/bjo.75.9.519","article-title":"Metipranolol associated granulomatous uveitis","author":"Akingbehin","year":"1991","journal-title":"Br J Ophthalmol"},{"key":"key-10.4103\/0301-4738.292592-63","first-page":"51","article-title":"Bilateral granulomatous uveitis as a side effect of topical brimonidine: Two case reports","author":"Hondeghem","year":"2009","journal-title":"Bull Soc Belge Ophtalmol"},{"key":"key-10.4103\/0301-4738.292592-64","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1016\/S0886-3350(03)00470-X","article-title":"Bilateral non-granulomatous anterior uveitis associated with bimatoprost","author":"Packer","year":"2003","journal-title":"J Cataract Refract Surg"},{"key":"key-10.4103\/0301-4738.292592-65","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1001\/jamaophthalmol.2017.0380","article-title":"Acute bilateral photoreceptor degeneration in an infant after vaccination against measles and rubella","author":"Kuniyoshi","year":"2017","journal-title":"JAMA Ophthalmol"},{"key":"key-10.4103\/0301-4738.292592-66","first-page":"48","article-title":"Vaccine-associated uveitis","author":"Benage","year":"2016","journal-title":"Mo Med"},{"key":"key-10.4103\/0301-4738.292592-67","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1080\/09273948.2019.1626188","article-title":"Vaccine-associated uveitis","author":"Cunningham","year":"2019","journal-title":"Ocul Immunol Inflamm"},{"key":"key-10.4103\/0301-4738.292592-68","doi-asserted-by":"crossref","first-page":"7231","DOI":"10.1016\/j.vaccine.2017.11.013","article-title":"Herpes zoster vaccine live: A 10 year review of post-marketing safety experience","author":"Willis","year":"2017","journal-title":"Vaccine"},{"key":"key-10.4103\/0301-4738.292592-69","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1055\/s-2003-38179","article-title":"Chorioretinitis induced by intravesical Bacillus Calmette-Gu\u00e9rin (BCG) instillations for urinary bladder carcinoma","author":"Guex-Crosier","year":"2003","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"key-10.4103\/0301-4738.292592-70","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1080\/09273948.2016.1265655","article-title":"Bacillus calmette-gu\u00e9rin infection and cytotoxicity in the retinal pigment epithelium","author":"Lloren\u00e7","year":"2018","journal-title":"Ocul Immunol Inflamm"},{"key":"key-10.4103\/0301-4738.292592-71","first-page":"213","article-title":"Recurrent uveitis after influenza vaccination","author":"Knopf","year":"1991","journal-title":"Ann Ophthalmol"},{"key":"key-10.4103\/0301-4738.292592-72","doi-asserted-by":"crossref","first-page":"363","DOI":"10.2147\/OPTH.S37443","article-title":"Multifocal choroiditis following simultaneous hepatitis A, typhoid, and yellow fever vaccination","author":"Escott","year":"2013","journal-title":"Clin Ophthalmol Auckl NZ"},{"key":"key-10.4103\/0301-4738.292592-73","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1080\/09273940600932311","article-title":"Multiple evanescent white dot syndrome following simultaneous hepatitis-A and yellow fever vaccination","author":"Stangos","year":"2006","journal-title":"Ocul Immunol Inflamm"},{"key":"key-10.4103\/0301-4738.292592-74","doi-asserted-by":"crossref","unstructured":"Garip A, Diedrichs-M\u00f6hring M, Thurau SR, Deeg CA, Wildner G. Uveitis in a patient treated with Bacille-Calmette-Gu\u00e9rin: Possible antigenic mimicry of mycobacterial and retinal antigens. Ophthalmology 2009;116:2457-62.","DOI":"10.1016\/j.ophtha.2009.05.021"},{"key":"key-10.4103\/0301-4738.292592-75","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3109\/15569520903427717","article-title":"Hepatitis B vaccine and uveitis: An emerging hypothesis suggested by review of 32 case reports","author":"Fraunfelder","year":"2010","journal-title":"Cutan Ocul Toxicol"},{"key":"key-10.4103\/0301-4738.292592-76","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0140-6736(87)93027-3","article-title":"Uveitis after hepatitis B vaccination","author":"Fried","year":"1987","journal-title":"Lancet Lond Engl"},{"key":"key-10.4103\/0301-4738.292592-77","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1080\/09273948.2018.1483520","article-title":"Vogt-Koyanagi-Harada disease associated with hepatitis B vaccination","author":"Sood","year":"2019","journal-title":"Ocul Immunol Inflamm"},{"key":"key-10.4103\/0301-4738.292592-78","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/S1726-4901(09)70435-6","article-title":"Optic neuritis following hepatitis B vaccination in a 9-year-old girl","author":"Erguven","year":"2009","journal-title":"J Chin Med Assoc JCMA"},{"key":"key-10.4103\/0301-4738.292592-79","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2174\/15748863113086660062","article-title":"Human papilloma virus vaccine associated uveitis","author":"Holt","year":"2014","journal-title":"Curr Drug Saf"},{"key":"key-10.4103\/0301-4738.292592-80","doi-asserted-by":"crossref","first-page":"967","DOI":"10.3928\/23258160-20151008-11","article-title":"Panuveitis with exudative retinal detachments after vaccination against human papilloma virus","author":"Dansingani","year":"2015","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"key-10.4103\/0301-4738.292592-81","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/bjo.2009.159293","article-title":"Ampiginous choroiditis following quadrivalent human papilloma virus vaccine","author":"Khalifa","year":"2010","journal-title":"Br J Ophthalmol"},{"key":"key-10.4103\/0301-4738.292592-82","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3928\/01913913-20160405-04","article-title":"Tubulointerstitial nephritis and uveitis syndrome associated with human papillomavirus vaccine","author":"Sawai","year":"2016","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"key-10.4103\/0301-4738.292592-83","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ajoc.2016.08.008","article-title":"Acute posterior multifocal placoid pigment epitheliopathy and granulomatous uveitis following influenza vaccination","author":"Gonome","year":"2016","journal-title":"Am J Ophthalmol Case Rep"},{"key":"key-10.4103\/0301-4738.292592-84","first-page":"180","article-title":"Acute posterior multifocal placoid pigment epitheliopathy following influenza vaccination","author":"Mendrinos","year":"2010","journal-title":"Eye Lond Engl"},{"key":"key-10.4103\/0301-4738.292592-85","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1080\/09273948.2017.1423334","article-title":"Multiple evanescent white dot syndrome following intradermal influenza vaccination","author":"Abou-Samra","year":"2019","journal-title":"Ocul Immunol Inflamm"},{"key":"key-10.4103\/0301-4738.292592-86","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1093\/clinids\/19.5.979","article-title":"Development of uveitis following vaccination for influenza","author":"Blanche","year":"1994","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"key-10.4103\/0301-4738.292592-87","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/ICB.0b013e318193491b","article-title":"Bilateral panuveitis after influenza vaccination","author":"Wells","year":"2009","journal-title":"Retin Cases Brief Rep"},{"key":"key-10.4103\/0301-4738.292592-88","first-page":"3838","article-title":"Two cases of exudative retinal detachment and uveitis following H1N1 influenza vaccination","author":"Tao","year":"2011","journal-title":"Chin Med J (Engl)"},{"key":"key-10.4103\/0301-4738.292592-89","doi-asserted-by":"crossref","first-page":"98","DOI":"10.4103\/0301-4738.178141","article-title":"Vogt-Koyanagi-Harada syndrome following influenza vaccination","author":"Kim","year":"2016","journal-title":"Indian J Ophthalmol","ISSN":"https:\/\/id.crossref.org\/issn\/0301-4738","issn-type":"print"},{"key":"key-10.4103\/0301-4738.292592-90","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1016\/j.jcjo.2015.05.016","article-title":"Two cases of panuveitis with orbital inflammatory syndrome after influenza vaccination","author":"Manusow","year":"2015","journal-title":"Can J Ophthalmol"},{"key":"key-10.4103\/0301-4738.292592-91","doi-asserted-by":"crossref","first-page":"bcr2015211971","DOI":"10.1136\/bcr-2015-211971","article-title":"Retinal artery vasculitis secondary to administration of influenza vaccine","author":"Williams","year":"2015","journal-title":"BMJ Case Rep"},{"key":"key-10.4103\/0301-4738.292592-92","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1001\/archinte.1980.00330180121037","article-title":"A possible association between influenza vaccination and small-vessel vasculitis","author":"Blumberg","year":"1980","journal-title":"Arch Intern Med"},{"key":"key-10.4103\/0301-4738.292592-93","doi-asserted-by":"crossref","first-page":"e368","DOI":"10.1097\/OPX.0000000000000682","article-title":"Bilateral iritis after vaccine for bladder cancer","author":"Parafita-Fern\u00e1ndez","year":"2015","journal-title":"Optom Vis Sci Off Publ Am Acad Optom"},{"key":"key-10.4103\/0301-4738.292592-94","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S0181-5512(06)73809-8","article-title":"[Panuveitis following intravesical bacille Calmette-Guerin therapy]","author":"Jacob","year":"2006","journal-title":"J Fr Ophtalmol"},{"key":"key-10.4103\/0301-4738.292592-95","first-page":"635","article-title":"Bilateral panuveitis and optic neuritis following Bacillus Calmette-Gu\u00e9rin (BCG) vaccination","author":"Hegde","year":"1992","journal-title":"Acta Paediatr Oslo Nor"},{"key":"key-10.4103\/0301-4738.292592-96","doi-asserted-by":"crossref","unstructured":"Uppal GS, Shah AN, Tossounis CM, Tappin MJ. Bilateral panuveitis following intravesical BCG immunotherapy for bladder carcinoma. Ocul Immunol Inflamm 2010;18292-6.","DOI":"10.3109\/09273948.2010.486099"},{"key":"key-10.4103\/0301-4738.292592-97","first-page":"23","article-title":"Unilateral panuveitis following intravesical therapy with bacille of Calmette et Guerin].Bull Soc Belge Ophtalmol","author":"Loukil","year":"2012","journal-title":""},{"key":"key-10.4103\/0301-4738.292592-98","first-page":"470","article-title":"Panuveitis and dermal vasculitis following MMR vaccination","author":"Sedaghat","year":"2007","journal-title":"East Mediterr Health J"},{"key":"key-10.4103\/0301-4738.292592-99","doi-asserted-by":"crossref","first-page":"e1035","DOI":"10.1542\/peds.2012-2930","article-title":"Anterior uveitis and cataract after rubella vaccination: A case report of a 12-month-old girl","author":"Ferrini","year":"2013","journal-title":"Pediatrics"},{"key":"key-10.4103\/0301-4738.292592-100","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1007\/s00417-010-1434-6","article-title":"Rubella virus as a possible etiological agent of Fuchs heterochromic iridocyclitis","author":"Suzuki","year":"2010","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"key-10.4103\/0301-4738.292592-101","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/ICO.0b013e318277acae","article-title":"Reactivation of herpes zoster keratitis in an adult after varicella zoster vaccination","author":"Hwang","year":"2013","journal-title":"Cornea"},{"key":"key-10.4103\/0301-4738.292592-102","first-page":"e4920","article-title":"Uveitis sarcoidosis presumably initiated after administration of shingrix vaccine","author":"Heydari-Kamjani","year":"2019","journal-title":"Cureus"},{"key":"key-10.4103\/0301-4738.292592-103","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/09273940802491892","article-title":"Herpes zoster keratouveitis and inflammatory ocular hypertension 8 years after varicella vaccination","author":"Lin","year":"2009","journal-title":"Occul Immunol Inflamm"},{"key":"key-10.4103\/0301-4738.292592-104","first-page":"130:1355","article-title":"Retinal necrosis following varicella-zoster vaccination","author":"Gonzales","year":"2012","journal-title":"Arch Ophthalmol"}],"container-title":["Indian Journal of Ophthalmology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:52:21Z","timestamp":1786733541000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijo.IJO_816_20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":104,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020]]}},"alternative-id":["292592"],"URL":"https:\/\/doi.org\/10.4103\/ijo.ijo_816_20","relation":{},"ISSN":["0301-4738"],"issn-type":[{"value":"0301-4738","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]}}}